Literature DB >> 17828597

Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Thomas Dittmar1, Christoph Heyder, Eva Gloria-Maercker, Wolfgang Hatzmann, Kurt S Zänker.   

Abstract

To date, cancer is still the second most prevalent cause of death after cardiovascular diseases in the industrialized word, whereby the primary cause of cancer is not attributed to primary tumor formation, but rather to the growth of metastases at distant organ sites. For several years it was considered that the well-known phenomenon of organ-specific spreading of tumor cells is mostly a mechanical process either directed passively due to size constraints (mechanical trapping theory) or due to a fertile environment provided by the organ in which tumor cells can proliferate (seed and soil hypothesis). Both mechanisms strongly depend on the adhesive properties of tumor cells either to endothelial cells and/or cancer cells, which are facilitated by a variety of cell adhesion molecules including carbohydrates and integrins. Within the past years it became evident that the organ-specific metastatic spreading of tumor cells does not only rely on heterotypic and homotypic adhesive interactions, but also on the interplay of chemokines and their appropriate receptors. Moreover, the identification of cancer stem cells in various tumor tissues has opened new questions. Cancer stem cells possess self-renewal, differentiation, and tumor-initiating capacities. Thus these cells are ideal candidates to be the seed of a secondary tumor. In the present review we will give a brief overview about the complex process of organ-specific metastasis formation depending on the interplay of adhesion molecules, chemokines, and the putative role of cancer stem cells in metastasis formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828597     DOI: 10.1007/s10585-007-9095-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  235 in total

1.  High serum concentrations of Sialyl Lewisx predict multilevel N2 disease in non-small-cell lung cancer.

Authors:  Shinjiro Mizuguchi; Kiyotoshi Inoue; Takashi Iwata; Tatsuya Nishida; Nobuhiro Izumi; Takuma Tsukioka; Noritoshi Nishiyama; Takahiro Uenishi; Shigefumi Suehiro
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

Review 2.  Chemokines and their role in tumor growth and metastasis.

Authors:  J M Wang; X Deng; W Gong; S Su
Journal:  J Immunol Methods       Date:  1998-11-01       Impact factor: 2.303

3.  Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Authors:  Joseph Kim; Hiroya Takeuchi; Stella T Lam; Roderick R Turner; He-Jing Wang; Christine Kuo; Leland Foshag; Anton J Bilchik; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

4.  Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma.

Authors:  H E Wiley; E B Gonzalez; W Maki; M T Wu; S T Hwang
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

5.  The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

Authors:  Manit Arya; Hitendra R H Patel; Claire McGurk; Roger Tatoud; Helmut Klocker; John Masters; Magali Williamson
Journal:  J Exp Ther Oncol       Date:  2004-12

6.  Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents.

Authors:  S Chatterjee; A Matsumura; J Schradermeier; G Y Gillespie
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

7.  The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice.

Authors:  U M Wewer; L M Shaw; R Albrechtsen; A M Mercurio
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

8.  Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro.

Authors:  Azza Gramoun; Seema Shorey; Jill D Bashutski; S Jeffrey Dixon; Stephen M Sims; Johan N M Heersche; Morris F Manolson
Journal:  J Cell Biochem       Date:  2007-10-01       Impact factor: 4.429

9.  CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors.

Authors:  C Monteagudo; J M Martin; E Jorda; A Llombart-Bosch
Journal:  J Clin Pathol       Date:  2006-03-07       Impact factor: 3.411

10.  Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.

Authors:  Jeffrey A Nemeth; Michael L Cher; Zhao Zhou; Chadwick Mullins; Sunita Bhagat; Mohit Trikha
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more
  24 in total

1.  Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events.

Authors:  Amanda P Struckhoff; Jason R Vitko; Manish K Rana; Carter T Davis; Kamau E Foderingham; Chi-Hsin Liu; Lyndsay Vanhoy-Rhodes; Steven Elliot; Yun Zhu; Matt Burow; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

2.  Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.

Authors:  Jane McHowat; Gail Gullickson; Richard G Hoover; Janhavi Sharma; John Turk; Jacki Kornbluth
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-12       Impact factor: 4.249

Review 3.  Modeling tumor microenvironments in vitro.

Authors:  Mingming Wu; Melody A Swartz
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

4.  Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity.

Authors:  Gordana Radosavljevic; Ivan Jovanovic; Ivana Majstorovic; Maja Mitrovic; Vanda Juranic Lisnic; Nebojsa Arsenijevic; Stipan Jonjic; Miodrag L Lukic
Journal:  Clin Exp Metastasis       Date:  2011-03-26       Impact factor: 5.150

5.  Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells.

Authors:  Thomas Dittmar; Sarah Schwitalla; Jeanette Seidel; Sonja Haverkampf; Georg Reith; Sönke Meyer-Staeckling; Burkhard H Brandt; Bernd Niggemann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2010-10-28       Impact factor: 5.150

Review 6.  Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver.

Authors:  Peter Thomas; R Armour Forse; Olga Bajenova
Journal:  Clin Exp Metastasis       Date:  2011-09-07       Impact factor: 5.150

Review 7.  The roles of Galectin-3 in autoimmunity and tumor progression.

Authors:  Gordana Radosavljevic; Vladislav Volarevic; Ivan Jovanovic; Marija Milovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Daniel K Hsu; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

8.  Analysis of cell migration within a three-dimensional collagen matrix.

Authors:  Nadine Rommerswinkel; Bernd Niggemann; Silvia Keil; Kurt S Zänker; Thomas Dittmar
Journal:  J Vis Exp       Date:  2014-10-05       Impact factor: 1.355

9.  Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.

Authors:  Chun-Liang Chen; Devalingam Mahalingam; Pawel Osmulski; Rohit R Jadhav; Chiou-Miin Wang; Robin J Leach; Tien-Cheng Chang; Steven D Weitman; Addanki Pratap Kumar; Luzhe Sun; Maria E Gaczynska; Ian M Thompson; Tim Hui-Ming Huang
Journal:  Prostate       Date:  2012-12-31       Impact factor: 4.104

Review 10.  Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?

Authors:  Mahendra P Deonarain; Christina A Kousparou; Agamemnon A Epenetos
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.